Responses
Infections
Letter
Does an adjustment to the dosing and timing of immunomodulatory drugs alter the immunogenicity of the COVID-19 vaccines in patients with autoimmune and inflammatory rheumatic disease (AIIRD)?
Compose a Response to This Article
Other responses
No responses have been published for this article.